Table 1 Ten-year FFTF after various... | American Society of Hematology

Table 1

Ten-year FFTF after various approaches to treatment of NLPHL

Stages included	n	Treatment	10-y FFTF estimate (%)	Reference
RT studies
I–II, A or B	312	IFRT or EFRT 48% or RT+ABVD type chemo 52%	∼75	1
IA	45	IFRT	94	4
IA	45	EFRT	84	4
IA, IIA	46	EFRT	77	5
	35	IRRT	83
	25	IFRT	66
IA, IIA	202	EFRT 76%	88	6
IA, IIA	202	IFRT 24%	88	6
RT + chemo studies
IA	41	RT+ABVD type chemo	94	4
I–II, A or B	56	RT+ABVD type chemo 75% or ABVD alone (4 cycles) 25%	98	2

Stages included	n	Treatment	10-y FFTF estimate (%)	Reference
RT studies
I–II, A or B	312	IFRT or EFRT 48% or RT+ABVD type chemo 52%	∼75	1
IA	45	IFRT	94	4
IA	45	EFRT	84	4
IA, IIA	46	EFRT	77	5
	35	IRRT	83
	25	IFRT	66
IA, IIA	202	EFRT 76%	88	6
IA, IIA	202	IFRT 24%	88	6
RT + chemo studies
IA	41	RT+ABVD type chemo	94	4
I–II, A or B	56	RT+ABVD type chemo 75% or ABVD alone (4 cycles) 25%	98	2

ABVD type chemo, ABVD, COPP/ABVD, or BEACOPP chemotherapy; EFRT, extended field radiation; IFRT, involved field RT; IRRT, involved region RT; RT, radiation.